Your browser doesn't support javascript.
loading
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selection.
Aoki, Yasunori; Röshammar, Daniel; Hamrén, Bengt; Hooker, Andrew C.
Affiliation
  • Aoki Y; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. yaoki@uwaterloo.ca.
  • Röshammar D; National Institute of Informatics, Tokyo, Japan. yaoki@uwaterloo.ca.
  • Hamrén B; Quantitative Clinical Pharmacology, Innovative Medicines and Early Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Hooker AC; SGS Exprimo, Mechelen, Belgium.
J Pharmacokinet Pharmacodyn ; 44(6): 581-597, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29103208
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nonlinear Dynamics / Anti-Asthmatic Agents / Indoles / Acetates Type of study: Guideline / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Pharmacokinet Pharmacodyn Journal subject: FARMACOLOGIA Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nonlinear Dynamics / Anti-Asthmatic Agents / Indoles / Acetates Type of study: Guideline / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Pharmacokinet Pharmacodyn Journal subject: FARMACOLOGIA Year: 2017 Document type: Article Affiliation country: